Turning Point Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 24 U.S.-traded ETFs. TPTX has around 721.1K shares in the U.S. ETF market. The largest ETF holder of TPTX is the SPDR S&P Biotech ETF (XBI), with approximately 242.23K shares. Investors may also find of interest that the ETF with the largest allocation to TPTX stock is Principal Healthcare Innovators Index ETF (BTEC), with a portfolio weight of 0.48%. On average, U.S. ETFs allocate 0.05% of TPTX to their portfolios.
Additionally, TPTX is a favorite stock for Vanilla and Value ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with TPTX as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 30.16%.